Plant-produced mouse zona pellucida 3 peptide, its immunogenicity and contraceptive efficacy

doi:10.21203/rs.3.rs-1862036/v1

PDF

Research Article

Plant-produced mouse zona pellucida 3 peptide, its immunogenicity and contraceptive efficacy

https://doi.org/10.21203/rs.3.rs-1862036/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Fertility control is a promising method for controlling the population of highly fertile species such as wild mice. Immunization with the mouse-specific contraceptive zona pellucida 3 peptide (mZP3) reduces fertility in some mouse strains, including wild mice. Here, we employed a plant expression system for the production of glycosylated mZP3 and evaluated the immunogenicity of plant-produced mZP3-based antigens in a female BALB/c mouse model. In the mZP3-1 antigen, mZP3 fused with a T-cell epitope of tetanus toxoid, a histidine tag and a SEKDEL sequence. A fusion antigen (GFP-mZP3-1) and a polypeptide antigen containing three repeats of mZP3 (mZP3-3) were also examined. Glycosylation of mZP3 should be achieved by targeting proteins to the endoplasmic reticulum. Agrobacterium-mediated transient expression of antigens resulted in successful production of mZP3 in Nicotiana benthamiana leaves. Compared with mZP3-1, GFP-mZP3-1 and mZP3-3 increased the production of the mZP3 peptide by more than 20 and 25 times, respectively. The glycosylation of the proteins was indicated by their size and their binding to a carbohydrate-binding protein. Both plant-produced GFP-mZP3-1 and mZP3-3 antigens were immunogenic in mice; however, mZP3-3 generated significantly higher levels of serum antibodies against mZP3. Although, as previously reported, the formation of antibodies did not lead to a significant reduction in fertility in BALB/c mice, strong and specific binding of antibodies to wild mouse zona pellucida was observed. Therefore, we assume that the plants might be an efficient system for the production of mZP3-3 as a contraceptive vaccine to reduce fertility in wild mice.

Wildlife population control

immunocontraception

zona pellucida 3

recombinant protein

plant-produced vaccine

Nicotiana benthamiana

The contraceptive mouse zona pellucida 3 glycopeptide was efficiently produced in Nicotiana benthamiana. Plant-produced mZP3-based antigens stimulated specific antibodies that reacted to the native zona pellucida in wild mouse ovaries.

Rodents are among the most important vertebrate pests in many parts of the world, causing economic, social, and environmental costs and damage (Stenseth et al. 2003; Jacob 2008). Mice, in particular, are considered serious agronomic pests both in the preharvest and postharvest stages. They disrupt the production and storage of various crops by the severe damage they directly and indirectly cause through consumption, spoilage, and contamination (Kaboodvandpour and Leung 2010; Wondifraw et al. 2021). Mice inflict significant yield losses on agricultural and livestock products; moreover, they can endanger public health by spreading diseases to humans (Stenseth et al. 2003; Firth et al. 2014; Brown and Henry 2022). Therefore, controlling rodent pest species is an important issue. The most common control techniques rely on lethal methods such as poison baiting and trapping (Singleton et al. 2007). Conventional control methods are associated with concerns about safety, specificity, animal welfare, and environmental impact. Consequently, there has been growing interest in developing more humane techniques that are cost-effective, species-specific, and environmentally friendly to control mouse populations (Tran and Hinds 2013).

In this regard, fertility control is an interesting alternative for controlling vertebrate pests, including mice (Chambers et al. 1997; Jackson 1998; Redwood et al. 2007b; Tran and Hinds 2013). Contraception by induced immunity (immunocontraception) is a fertility regulation method using the immune system to disrupt reproductive function and prevent fertilization (Chambers et al. 1997; Barber and Fayrer-Hosken 2000 Paterson et al. 2000). Contraceptive vaccines evoke an immune response to molecules having indispensable roles in the reproduction process. Several proteins have been used successfully to reduce the fertility of various animal species, including antigens associated with sperm (Naz 2008; Choudhury et al. 2009; Mou and Xie 2017) and oocytes (Miller et al. 2000; Gupta et al. 2011; Garside et al. 2014), as well as hormones and their receptor proteins (Khan et al. 2008; Samoylov et al. 2019). The unique specificity of sperm and oocyte proteins makes them ideal candidates for immunocontraceptive vaccines. The oocyte-specific protein zona pellucida (ZP), with a pivotal role in the process of fertilization, has been proposed as one of the most desirable targets for the development of contraceptive vaccines (Barber and Fayrer-Hosken 2000; Naz 2005). The ZP is a glycoprotein matrix that surrounds the plasma membrane of all mammalian oocytes. In mammals, the ZP is composed of either three or four glycoproteins. Antigens derived from the ZP protein subunits have successfully induced an immunocontraceptive effect in various species of mammals (Paterson et al. 2000; Bechert et al. 2013). In mice, the ZP matrix consists of three glycoproteins conventionally known as ZP1, ZP2, and ZP3 (Bleil, J.D., Wassarman, P.M. 1980; Prasad et al. 2000; Avella et al. 2013). ZP3 protein-based antigens have been reported to have a strong contraceptive effect and lead to reduced fertility in many species when injected (Gupta et al. 2004; Hardy et al. 2006; Naz and Saver 2016). However, injectable immunocontraceptives are clearly not suitable for field applications for controlling the population of small and large-scale dispersed animals such as wild mice. The availability of oral immunocontraceptive vaccines could increase the scope of contraceptive applications for wildlife population control and facilitate mouse population management.

Oral application of vaccine baits necessitates species specificity in the contraceptive antigens to avoid affecting the fertility of non-target animals. The development of peptide-based contraceptive vaccines is an attractive approach for producing species-specific antigens (Sun 1999; Hardy et al. 2004; Hardy et al. 2008) and thereby allowing oral application to control the wildlife population. Targeting rodent-specific peptides from areas of ZP proteins that are less conserved between species has been predicted to increase the target specificity of contraceptive vaccines (Hinsch et al. 1999; Hardy et al. 2002b; Hasegawa et al. 2002). In mice, the ZP3 protein plays a key role during fertilization as the primary receptor for sperm and the inducer of the sperm acrosome reaction (Ringuette et al. 1988; Kinloch et al. 1995; Wassarman et al. 2004). A glycopeptide of ZP3 corresponding to amino acid residues 328–343 has been suggested to be directly involved in these activities (Kinloch et al. 1995; Chen et al. 1998). Vaccines based on the mZP3 contraceptive peptide appear to have the desired properties. First, immunization of mice with synthetic or recombinant forms of this peptide and other closely related peptides has reduced fertility in some mouse strains, including wild mice (Millar et al. 1989; Lou et al. 1995; Sadler et al. 2000; Hardy et al. 2002a; Choudhury et al. 2009). Second, it has not been detected immunologically in other species such as hamster, guinea pig, cat, or dog (East et al. 1985; Millar et al. 1989; Fitchen 1995). Therefore, the mZP3 peptide is considered a promising target for developing a mouse-specific contraceptive vaccine (Hardy et al. 2002a; Hardy et al. 2004). However, in many cases, peptide-based vaccines have lower immunogenicity than protein antigens (Ferro and Mordini 2004). Integrating adjuvants such as a ‘promiscuous’ T-cell epitope from tetanus toxoid, which is reported to be a universal immunogenic epitope, is an approach towards improving the efficacy of peptide-based vaccines (Kaumaya et al. 1993; Pinkhasov et al. 2011; Fraser et al. 2014; Arukha et al. 2016). Furthermore, the use of repeated peptide epitopes has been shown to enhance the immunogenicity of contraceptive peptide-based vaccines (Hardy et al. 2002b; Hardy et al. 2004; Redwood et al. 2007a).

Transgenic plants are ideal production platforms for producing oral vaccines. Plants offer several advantages compared to other available conventional systems, such as bacterial and mammalian cell-based production systems. Plant expression systems are considered rapid, cost-effective, and safe platforms for the large-scale production and delivery of vaccines (Streatfield and Howard 2003; Daniell et al. 2015). In addition, plants have the ability to produce functional proteins with eukaryotic post-translational modifications including glycosylation, which are often required for the biological activity and function of many mammalian proteins. Furthermore, plant expression systems provide safety benefits, as they greatly reduce the risk of contamination and transmission of mammalian pathogens from the host (Moloney 1995; Ma et al. 2003). Nevertheless, the expression of small proteins can be a challenge to eukaryotic expression systems (Demain and Vaishnav 2009). Several studies have illustrated the positive effect of protein fusion as a strategy to improve the production of recombinant proteins in plant production systems (Benchabane et al. 2008).

Plant-derived recombinant proteins can be expressed either by stable transformation or through transient expression. The latter approach provides for rapid production of high yields of recombinant proteins compared to time-consuming stable transformation (Komarova et al. 2010). MagnICON technology is a transient expression system based on a plant viral vector, with the potential of producing recombinant protein up to 80% of total soluble protein (Marillonnet 2004). This system combines the advantages of different biological systems, including the efficient DNA delivery of Agrobacterium tumefaciens, the speed and high expression levels of a plant RNA virus, as well as posttranslational modifications and low cost of plant expression systems (Gleba et al. 2005; Marillonnet et al. 2005).

In this study, we explored the potential of plants for producing glycosylated contraceptive antigens using the MagnICON expression system in N. benthamiana. We chose a mouse-specific glycopeptide from ZP3 (mZP3, amino acids 328–342) as the contraceptive epitope for constructing the antigens. The T-cell help for eliciting an immune response was provided by inclusion of T-cell epitope from tetanus toxoid (TT) (Fraser et al. 2014). The objectives of this study were to evaluate the production of glycosylated mZP3- based antigens in N. benthamiana, to evaluate the antibody responses induced by immunization with plant-produced antigens and to evaluate contraception of female mice after stimulation of antibody production.

Construction of plant expression vectors

The coding sequences of mZP3-1 (containing a copy of mZP3 peptide) and mZP3-3 (containing three copies of mZP3 peptide) constructs were designed and codon optimized for expression in N. benthamiana (Supplementary, Fig. S1). The gene constructs were synthesized by Eurofins Genomics GmbH (Ebersberg, Germany) and cloned into the pEX-A vector. To construct GFP-mZP3-1, the green fluorescent protein (GFP) coding region was amplified from the vector pICH18711 (Marillonnet 2004) and fused to the 3′ end of the mZP3-1 by overlapping PCR. All coding regions were flanked by BsaI restriction sites using PCR amplification. The PCR products were cloned separately into the pJET1.2 cloning vector (CloneJET PCR Cloning Kit, Thermo Fisher). Subsequently, the gene sequences were inserted into the TMV-based expression vector pICH31120 of the MagnICON system with BsaI restriction/ligation (Engler et al. 2008). The MagnICON™ vectors were kindly provided by Nomad Bioscience (Halle/Saale, Germany). The binary MagnICON vector pICH31120 and the expression constructs are shown in Fig. 1.

Agroinfiltration procedure

Expression vectors with their cassettes were separately electroporated into Agrobacterium tumefaciens strain ICF320. Transformed colonies were inoculated into 5 ml Luria–Bertani (LB) media supplemented with 50 µg/ml kanamycin and 50 µg/ml rifampicin and incubated overnight at 28°C in a shaking incubator (220 rpm). Two milliliters of the Agrobacterium suspensions were diluted into 200 ml cultures containing the same antibiotics and grown at 28°C/220 rpm overnight. The agrobacterial cells were harvested by centrifugation at 4560 × g for 30 min at room temperature (RT) and resuspended in infiltration buffer [10 mM 2-(N-morpholino) ethanesulfonic acid (MES), pH 5.8, 10 mM MgSO₄, 0.02% Silwet Gold] to a final OD₆₀₀ of 0.15–0.2. Transient expression was carried out by vacuum-agroinfiltration of 6- to 8-week-old N. benthamiana grown in the greenhouse (Nausch and Broer 2017).

Total soluble protein extraction from N. benthamiana leaves

Agroinfiltrated N. benthamiana leaves were harvested at various days post-infiltration (dpi), lyophilized using a freeze dryer system and ground. Total soluble protein (TSP) was extracted from freeze-dried leaf material (25 mg) homogenized in 500 µl ice-cold extraction buffer using a Precellys 24 homogenizer (Bertin Instruments, France). The extract was clarified by repeated centrifugation at 15000 × g for 15 min at 4°C. The supernatant was collected as the TSP fraction, and the protein concentration was measured using the Pierce™ Coomassie Plus (Bradford) assay kit (Thermo Scientific, USA), with bovine serum albumin (BSA) as the standard.

Ni-NTA purification

His-tagged recombinant mZP3-1, GFP-mZP3-1, and mZP3-3 were purified using immobilized metal affinity chromatography (IMAC) based on the affinity for the 6His purification tag. For large-scale protein extraction, 30 g of ground leaf material was homogenized in ice-cooled protein extraction buffer (50 mM NaH₂PO₄, 300 mM NaCl, 250 mM sucrose, 5 mM imidazole) using a Homogenizer (Polytron® PT 2100, Kinematica AG, Switzerland) for 30 s at 30,000 rpm. Lysates were centrifuged at 4600 × g for 15 min and then clarified by repeated ultracentrifugation at 16,000 × g for 30 min at 4°C. The supernatants were collected and loaded onto a column (Bio-Rad Laboratories, USA) containing pre equilibrated Nuvia™ IMAC Ni-charged resin (Bio-Rad Laboratories, USA). The column was washed with washing buffer (50 mM NaH₂PO₄, 20 mM imidazole, 20 mM NaCl, pH 8). The target recombinant protein was further eluted with elution buffer (50 mM NaH₂PO₄, 300 mM imidazole, 300 mM NaCl, pH 8). The elution fraction was concentrated and desalted using Vivaspin 20 centrifugal concentrators with a 10 kDa cut-off membrane (Sartorius AG, Germany).

SDS–PAGE and Western blot analysis

Protein extracts were mixed with loading buffer (150 mM Tris, pH 6.8, 10% glycerin, 3% SDS, 1% β-mercaptoethanol, and 2.5% bromophenol blue) and denatured at 95°C for 5 min. The proteins were separated under denaturing conditions using 12% SDS–PAGE and then electroblotted onto a nitrocellulose membrane (GE Healthcare Europe GmbH, Germany) via wet transfer at 100 V for 30 min. Membranes were blocked for 2 h with 5% (w/v) nonfat milk powder in TBS containing 20 mM Tris, 150 mM NaCl, and 0.05% (v/v) Tween 20 (TBST, pH 7.6). After three washes with TBST, membranes were probed with mouse monoclonal anti-His antibodies (Dianova, Hamburg, Germany) (1:1,000 dilution) for 2 h at RT. Following another washing step, the membranes were probed with horseradish peroxidase (HRP)-conjugated donkey anti-mouse antibodies (Dianova, Hamburg, Germany) (1:10,000 dilution) for 1 h at RT. After a final wash with TBS, proteins were detected with the enhanced chemiluminescence technique using a Kodak Biomax light X-ray film (VWR; Darmstadt, Germany). Concanavalin A (Con A) Western blot analysis was conducted as described by (Nausch and Broer 2017) to visualize the glycosylation of recombinant proteins.

Enzyme-linked Immunosorbent Assay (ELISA)

The content of mZP3 peptide was determined using ELISA in 96-well microtiter plates. Briefly, the plate was coated with diluted leaf extract in carbonate buffer (pH 9.6) for 2 h at RT and washed three times with PBS containing 0.05% Tween 20 (PBST). The plate was blocked with 1X RotiBlock blocking solution (Carl-Roth GmbH & Co.) for 1 h at RT and washed as previously described. Rabbit anti-mZP3 primary antibody (Bioserv, Rostock, Germany) was added at a 1:500 dilution in PBS, incubated at RT for 2 h and then washed three times. The plate was then incubated for 1 h at RT with HRP-conjugated goat anti-rabbit secondary antibodies (Dianova, Hamburg, Germany) at a 1:2000 dilution in PBS. Tetramethylbenzidine (TMB) substrate was added to each well to develop the color in the dark for 10 min, and the reaction was stopped with 250 mM H₂SO₄. Absorbance was read at 450 nm.

Mouse Immunization

The animal experiments were performed in accordance with the German animal protection regulations and were approved by the relevant authorities (Landesamt fur Landwirtschaft, Lebensmittelsicherheit und Fischerei, Mecklenburg-Vorpommern, Germany; permission No. 7221.3-1-073/17 and 7221.3-3.2-002/22).

Female BALB/c mice (6–8 weeks old, five mice per group) were primary immunized and boosted two times at three week intervals by subcutaneous injection. Treatment groups received 50 µg mZP3 in the form of GFP-mZP3-1 or mZP3-3 recombinant protein, and the control group received PBS. All doses contained 10% Polygen (MVP Lab) as an adjuvant. Serum samples were collected before primary immunization and two to three weeks after each immunization. Female BALB/c mice were mated with proven fertile BALB/c males of similar age three weeks after the final immunization. Males were removed after 2 weeks, and the females were allowed to litter.

Detection of the antibody titer using ELISA

The specific IgG responses in serum were determined using endpoint titer ELISA. Briefly, a 96-well plate was coated with 50 µl of plant-produced mZP3 (0.5 µg per well) and incubated at RT for 2 h. Nonspecific binding was prevented by incubation in PBS buffer containing 1% (w/v) BSA for 1 h at RT. The plates were washed three times with PBST and incubated with serum samples (50 µl per well) serially diluted in PBS at RT for 2 h. Then, the plate was incubated with HRP-conjugated donkey anti-mouse secondary antibodies (Dianova, Hamburg, Germany) at a dilution of 1:2000 in PBS at 37°C for 1 h. The plate was washed, and the color was developed with TMB substrate solution (100 µl per well). After 12 min, the reaction was terminated by adding 100 µl of 250 mM H₂SO₄. Absorbance values were determined at 450 nm.

Indirect Immunofluorescence

Mouse ovarian sections were provided by BIOSERV Analytik (Rostock, Germany). Sections were deparaffinized and subjected to antigen retrieval using sodium citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0). Sections were blocked with 10% goat serum blocking solution (Life Technologies, USA) at RT for 1 h, rinsed with PBS, and incubated in 1x mouse-on-mouse IgG blocking solution (Invitrogen, Thermo Fisher Scientific, US) at RT for 1 h. Sections were incubated with a 1:30 dilution of serum samples and kept at 4°C overnight. The sections were washed and incubated with 10 µg/mL fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Thermo Fisher Scientific, Invitrogen, US) as a secondary antibody for 1.5 h at 37°C. After washing, the slides were mounted with DAPCO mounting medium (25 mg/ml DABCO, 90% glycerol, 10% PBS, pH 8.5) and observed under a fluorescence microscope. The sections were stained with methylene blue for bright-field microscopy.

Histological analysis

On day 99 of the experiment, one mouse from each group was sacrificed. The ovaries were collected, fixed in 4% paraformaldehyde and then paraffin embedded. The ovaries were sectioned at 5 µm, stained with hematoxylin and eosin, and observed under a microscope.

Statistical analysis

The experimental data were analyzed using IBM SPSS statistical software version 27. The comparison of means was performed using one-way analysis of variance (ANOVA). The statistically significant differences are shown with one asterisk (*), indicating p values < 0.05, and two asterisks (**), indicating p values < 0.001.

Construction of expression vectors for transient expression

The mouse Zona pellucida 3 peptide CSNSSSSNSSSSQFQ (mZP3), corresponding to amino acids 328–342, contains a T-cell and a B-cell epitope (Millar et al., 1989; Rhim et al., 1992; Hardy et al. 2002). To assess the expression of mZP3 in plants and immunogenicity of plant-made recombinant mZP3 in mice, three gene constructs (mZP3-1, GFP-mZP3-1, and mZP3-3) were developed (Fig. 1b). In the mZP3-1 construct, a promiscuous T-cell epitope (aa residues 830–844) of TT was fused at the N-terminus of the mZP3 sequence using a flexible GS linker to enhance the immunogenicity of the antigen (Fraser et al. 2014). To facilitate the purification of recombinant protein, a 6×His tag was fused at the C-terminal end of mZP3. The retention in the endoplasmic reticulum (ER) was achieved through the addition of a SEKDEL retention signal at the C-terminus of the construct. The GFP-mZP3-1 construct was developed by fusing the mZP3-1 construct to GFP via a dilysine linker (KK). In the mZP3-3 construct, the antigenic peptide was tripled by linking three repeated copies of mZP3 via GS linkers. All three resulting constructs were codon optimized for N. benthamiana to increase protein expression and cloned into the MagnICON-based plant expression vector pICH31120 to target the expression of proteins into the ER.

Optimization of mZP3 expression in N. benthamiana

N. benthamiana plants were infiltrated with the resulting vectors in three independent repetitions. Protein expression was examined following transient expression in Agrobacterium-infiltrated leaves. The leaves were harvested at different days post-infiltration (dpi), and total soluble proteins were extracted and determined with a Bradford assay. Time-course evaluation of protein expression levels of each construct was performed using Western blot probed with anti-His monoclonal antibodies. The optimal harvest time of recombinant proteins was determined based on the accumulation of target proteins and morphology of the infiltrated leaves. Western blot analysis of TSP from leaves infiltrated with mZP3-1 showed no protein band corresponding to the expected size of the mZP3-1 protein (Supplementary, Fig. S2). However, a strong band of a protein with a molecular mass of ∼37 kDa was detected in the total soluble protein extracts from leaves infiltrated with GFP-mZP3-1. Protein accumulation was observed in all selected leaves. The protein expression increased and reached the highest level at 8 dpi and gradually declined thereafter (Fig. 2-left). In crude extract from mZP3-3-expressing leaves, Western blot analysis of protein revealed a band of ∼18 kDa. Accumulation of the protein was observed from 5 dpi to 7 dpi, while the protein was barely detectable before and after this time (Fig. 2-right). A higher molecular mass band (∼36 KDa) was also presented, which appeared to be the multimer form of the protein.

Using the ProtParam tool (expasy.com), the molecular masses of the nonglycosylated forms of GFP-mZP3-1 and mZP3-3 were estimated to be 34.7 and 11 kDa, respectively. Plant-produced proteins showed higher molecular masses than expected for unglycosylated proteins. This finding pointed to the possible addition of glycan chains during expression in plants and retention in the ER, since the mZP3 peptide carries two potential glycosylation sites. The presence of glycans on the plant-produced GFP-mZP3-1 and mZP3-3 proteins was assessed with lectin blotting using peroxidase-conjugated concanavalin A (Con A), which has a high affinity for binding to sugar residues. Western blots of recombinant GFP-mZP3-1 and mZP3-3 probed with Con A identified carbohydrates and revealed dominant bands of ∼37 kDa and ∼18 kDa, respectively (Fig. 3). This result indicated that the observed protein bands corresponded to glycosylated forms of the GFP-mZP3-1 and mZP3-3 recombinant proteins.

Protein analysis showed that GFP-mZP3-1 and mZP3-3 targeted to the ER were successfully produced in N. benthamiana plants. Based on the plant morphology and highest accumulation of proteins in plants, the optimal harvest time for GFP-mZP3-1- and mZP3-3-infiltrated leaves was determined to be approximately 8 dpi and 6 dpi, respectively.

All infiltrated plants displayed morphological disorders from chlorosis to necrosis and finally leaf death, although at different dpi. In the case of mZP3-1, necrosis started on day 3 and increased rapidly, resulting in plant death by day 7 (Fig. 4a). However, when the plants were infiltrated with the GFP-mZP3-1 fusion construct, the phenotypic effects were less pronounced, and symptoms of chlorosis began on day 7 (Fig. 4b). In plants infiltrated with mZP3-3, leaves started to show necrosis at 4 dpi. Wilting was observed on day 7 and resulted in plant death by day 10 (Fig. 4c). mZP3-3 expression caused moderate leaf necrosis compared to mZP3-1, although it was more severe than GFP-mZP3-1 expression.

Purification and characterization of plant-produced mZP3 antigens

Purification of plant-produced mZP3-1, GFP-mZP3-1 and mZP3-3 proteins was carried out under non-denaturing conditions through Ni²⁺-charged column chromatography. Fractions were collected and subjected to SDS–PAGE followed by Western blots probed with mouse anti-His monoclonal antibodies. Although mZP3-1 was not detectable in crude protein extracts, analysis of the concentrated purified protein from the chromatography column revealed bands of proteins that confirmed recombinant expression of mZP3-1 (Fig. 5). The Western blot profile showed a ∼12 kDa band corresponding to the expected size of the glycosylated mZP3-1 protein. No band corresponding to mZP3-1 was observed in the lectin blot using Con A. Bands with higher molecular mass were also observed in the Western blot, which are close to the molecular mass of oligomer forms of the mZP3-1 protein. The infiltrated plant leaves showed the highest expression of mZP3-1 at day 4 post infiltration; however, the yield of mZP3-1 was low compared to that of the other two proteins. Figure 5 illustrates 30x concentrated purified mZP3-1 compared to 1x purified GFP-mZP3-1 and mZP3-3 proteins.

The concentration of plant-made mZP3 peptide in crude protein extract and in antigens purified from N. benthamiana infiltrated leaves was quantified with ELISA. Compared with mZP3-1, GFP-mZP3-1 and mZP3-3 increased the production of the mZP3 peptide by more than 20 and 25 times, respectively (Table 1). However, among the three purified proteins, the highest concentration of mZP3 peptide was obtained in GFP-mZP3-1 (53.4 ± 1 µg/g DW). The purified mZP3-1 and mZP3-3 revealed 3.4 ± 0.8 µg/g DW and 32.7 ± 2.3 µg/g DW mZP3 peptide, respectively (Table 1). The accumulation of mZP3-1 was not sufficient for application in mouse vaccination. Therefore, only GFP-mZP3-1 and mZP3-3 were purified on a large scale from N. benthamiana leaves at the optimal harvest time and prepared for vaccination of female BALB/c mice. Ni-NTA affinity purified proteins were concentrated and desalted using Vivaspin™ ultrafiltration spin columns. Impurities were removed from samples using a 0.22 µm syringe filter.

Table 1

mZP3 accumulation levels in crude plant extract and in purified antigens, as determined using ELISA.
Antigen	Time point	mZP3 peptide/TSP (%)	Purified mZP3 (µg/g LDW)
mZP3-1	4 dpi	0.047 ± 0.006	3.4 ± 0.8
GFP-mZP3-1	8 dpi	0.95 ± 0.05	53.4 ± 1
mZP3-3	6 dpi	1.18 ± 0.12	32.7 ± 2.3
Infiltrated N. benthamiana leaves were collected at the optimal time point and evaluated for mZP3 expression by ELISA. Data are reported as the mean ± SEM from three independent infiltrated samples. dpi, days post-infiltration; TSP, total soluble protein; LDW, leaf dry weight

Immunogenicity of mZP3-based antigens

To determine whether the plant-produced mZP3-based antigens are immunogenic in mice, a prime-boost immunization assay was conducted (Fig. 6a). Two groups of five female BALB/c mice were immunized and boosted two times at three week intervals with either recombinant GFP-mZP3-1 or mZP3-3 containing 50 µg mZP3 peptide. Additionally, the third group of five mice received PBS as a control. The antibody responses of immunized mice were assessed using ELISA. Figure 6b illustrates the mean endpoint titer of IgG antibodies in preimmune sera and sera of the immunized mice after each immunization. Although an immune response was not observed after prime injection in GFP-mZP3-1-immunized mice, serum antibody responses increased greatly after the first booster and showed a significant difference compared to the control group. All GFP-mZP3-1-immunized mice produced detectable IgG antibodies at serum dilutions up to 1:8000 (log₂, 12.96) after the first boost dose. Antibody levels continued to increase in all vaccinated mice following the second boost dose. However, there were no detectable IgG antibody titers in all sera of control mice throughout the whole course (Fig. 6b).

In mice immunized with plant-produced mZP3-3, only one mouse produced detectable IgG antibodies at a 1:4000 dilution after the priming dose (data not shown). However, antibody titers increased drastically in the remaining animals after the first boost dose. Although there was variation between the IgG titers of individuals, antibody responses were detectable in all mZP3-3-immunized animals at serum dilutions higher than 1:8,000. The antibody titer subsequently increased in all mice following the second booster (Fig. 6b). Two mice showed antibody responses even up to a titer of 1:64,000 (log₂, 15.96) after the second boost injection.

These results indicated that both plant-produced antigens were capable of inducing antibodies against mZP3, which increased following each injection and reached the peak after the final boost dose. Figure 7 represents the comparison of antibody responses in mice from the three groups after the final boost injection at a 1:1,000 dilution. The results showed a significant difference not only between the experimental groups and control (p < 0.001) but also between the experimental groups (Fig. 7). Mice immunized with the plant-produced mZP3-3 antigen elicited a significantly higher antibody response (p < 0.05) than those immunized with the GFP-mZP3-1 antigen after the second booster.

Fertility and ovarian effects in BALB/c mice immunized with mZP3 antigens

To assess the fertility of female mice immunized with GFP-ZP3-1 or mZP3-3 antigens or PBS, individuals were mated with BALB/c males of similar age three weeks after the final immunization. Female mice were allowed to produce litters. The results showed that there was no significant reduction in the fertility or litter size of mice immunized with plant-produced GFP-ZP3-1 or mZP3-3 antigens. All animals in the treated groups and control group were fertile. No significant reduction in the mean litter size of mice immunized with recombinant GFP-mZP3-1 was achieved (Table 2). Although one animal from the mZP3-3 group showed a reduction in litter size, the mean litter size of this group was not significantly different from that of the control group (Table 2). The mean litter sizes of mice immunized with GFP-mZP3-1 (5.7 ± 0.6) and mZP3-3 (7 ± 1.5) were not significantly different from those of control mice (7 ± 0.9).

Histological examination of the ovaries of immunized mice showed no evidence of oophoritis or disrupted folliculogenesis. The ovaries demonstrated normal follicles at different stages of development (Fig. 8).

Table 2

Fertility of BALB/c mice immunized with recombinant mZP3-based antigens.
Antigen	Total mice	Number of injection	Number of Fertile mice	Litter size (Mean ± SEM)	P
GFP-mZP3-1	5	3	5/5	5.7 ± 0.6	N/S
mZP3-3	5	3	5/5	7 ± 1.5	N/S
PBS	5	3	5/5	7 ± 0.9
Female BALB/c mice were immunized and boosted two times at three-week intervals with antigens in Polygen adjuvant and mated three weeks after the final boost. Values are means ± SEM. The P value indicates a significant difference (p < 0.05) between the treated and control groups. N/S, not significant

Reactivity of serum antibodies with the mouse ZP matrix by indirect immunofluorescence

An indirect immunofluorescence assay was conducted to evaluate the binding of serum antibodies to the ZP matrix in BALB/c and wild mice. The results showed that the antibodies generated against the plant-produced GFP-mZP3-1 or mZP3-3 did not react with the ZP matrix surrounding the oocytes in BALB/c mice. Fluorescence signals from immune sera were similar to those of pre-immune serum samples (Fig. 9a). However, immunofluorescence studies with wild mouse ovarian sections showed that serum antibodies from both immunized groups recognized the ZP matrix. Immune sera of immunized mice bound to the ZP of wild mouse ovarian sections, whereas pre-immune serum samples from the same animal did not show reactivity to the ZP matrix (Fig. 9b).

In the face of an overpopulation of mice, developing a species-specific, inexpensive, effective, and readily applicable contraceptive vaccine is required to allow oral application. This study aimed to develop an immunocontraceptive vaccine based on the mZP3 glycopeptide in plants.

To develop contraceptive vaccines targeting wild mouse populations, an effective mouse-specific antigen is needed. Vaccines based on the mZP3 peptide appear to be promising since the peptide has been found to be sufficiently immunogenic and contraceptive in wild mice (Hardy et al. 2002a). In addition, it is hypothesized to be mouse-specific because it has not been detected in other species such as hamster, guinea pig, cat or dog (East et al. 1985; Millar et al. 1989). Therefore, it might be a good choice for producing a mouse-specific contraceptive vaccine in transgenic plants that is a suitable platform for the rapid, low-cost and large-scale production of vaccines (Ma et al. 2003; Streatfield and Howard 2003; Sabalza et al. 2014). More importantly, transgenic plants can facilitate the administration of vaccines by providing a potential platform for the oral delivery of vaccines (Daniell et al. 2009; Chan and Daniell 2015), which could be an ideal method for vaccination of wild life populations.

To create an effective vaccine, it is necessary to produce a sufficient amount of stable antigen. Our results indicated that mZP3-1 was unstable, with accumulation levels dropping four days after infiltration, before the optimal day proposed for the expression system (Marillonnet 2004; Chen et al. 2013). The low mZP3-1 yield might be related to its susceptibility to proteolytic processes in the heterologous environment (Benchabane et al. 2008; Faye et al. 2005; Manning et al. 2010). Fusing recombinant peptides or proteins with a partner that is stably expressed in plants is one approach to increase the yield of target proteins in plants (Streatfield 2007). Fusion of mZP3-1 to the GFP coding region, resulting in GFP-mZP3-1, led to a more than 25-fold higher accumulation of mZP3. GFP has already been used successfully to improve protein production and stability under various conditions (Hsieh et al. 2010; Janczak et al. 2015; Ponndorf et al. 2017). This stabilization seems to depend not only on the GFP sequence but also on the protein size since mZP3-3 showed a similar effect on the stability and accumulation of the protein.

The low amounts of mZP3-1 could also be due to the massive damage that mZP3-1 production caused in the plants. It has already been observed that transient expression of ER-targeted proteins can put stress on plants and cause prohibitive levels of tissue necrosis that consequently lead to low yields of recombinant proteins (Diamos and Mason 2018; Hamorsky et al. 2015; Hussain et al. 2014). Expression of GFP-mZP3-1 and mZP3-3 reduced the severity of tissue necrosis and resulted in higher protein accumulation. Other studies have achieved an increase in target protein accumulation by reducing the ER stress response and moderating plant tissue necrosis (Diamos and Mason 2018; Margolin et al. 2020). Hence, differences in protein accumulation might be due not only to differences in protein stability but also to differences in the induction of plant stress responses.

The other necessity for an efficient vaccine is sufficient immunogenicity. Immunization of mice with mZP3-3 antigens led to the generation of significantly higher antibody responses against mZP3 compared to GFP-mZP3-1. In line with this, previous studies have shown that antigens containing multiple repeats of ZP3 epitopes stimulate higher antibodies in BALB/c mice compared with those containing single mZP3 epitopes (Sadler et al. 2000; Hardy et al. 2004). Incorporation of multiple copies of epitopes into antigens has been investigated previously for various weak immunogens to enhance their immunogenicity (Jinshu et al. 2004; Haigh et al. 2007; Sandam et al. 2021).

Notably, the production of mZP3 antigens in plants seems to increase immunogenicity compared to other production systems. E. coli-produced single mZP3-peptide antigens elicited no significant antibody responses to ZP3 in BALB/c immunized mice (Hardy et al. 2004), and ZP3 protein expressed in the insect cell-expression system (Hardy 2003) seems to induce lower levels of antibodies against mZP3 peptide compared to our study. These observations highlight the importance of the expression system for the production of recombinant ZP3 antigens and show the superiority of plants over other expression platforms in this case. Hardy 2003 demonstrated the importance of glycosylation in the efficiency of recombinant mouse ZP3 antigens as immunocontraceptive. Plants offer the ability to perform posttranslational modification of proteins in a similar, but not equal, way compared to mammalian proteins that can support the immunogenicity of plant-made vaccines (Streatfield and Howard 2003; Faye et al. 2005; Bosch and Schots 2010). Although glycosylation analysis was not carried out, the strong reaction of plant-produced proteins with the carbohydrate-binding protein Con A and the size of the proteins may be evidence for the glycosylation of the mZP3 peptide. Therefore, oligosaccharide residues present in plant-produced mZP3 may be a contributing factor in increasing the immunogenicity of antigens in vaccinated mice. Nevertheless, it might also indicate the stimulating effects of the TT epitope as an adjuvant. It has been observed previously that the antibody responses to ZP3 improved when additional appropriate T-cell helper epitopes were included in antigens (Jackson 1998; Sadler et al. 2000; Shrestha et al. 2014).

Wild mice cause huge problems in immunization and mating studies due to their aggressive behavior. Hence, we had to restrict studies with live animals to the laboratory BALB/c mice used in most previous studies, although they have not shown a significant reduction in fertility dependent on the induction of anti-mZP3 antibodies (Fitchen 1995; Hardy et al. 2002a; Hardy et al. 2004). Fertility of BALB/c mice was reduced by immunization with repeated mouse ZP3 peptides conjugated to multiple contraceptive epitopes and defined T helper cell epitopes (Sadler et al. 2000; Hardy et al. 2008). Accordingly, despite high anti-mZP3 antibody titers, reproduction rates were not significantly reduced in immunized mice. It has been suggested that contraception depends on additional factors such as mouse genetic background in combination with antibody levels (Fitchen 1995; Hardy et al. 2004). Immunization with mZP3 and other closely related peptides reduces fertility in some, but not all, mouse strains, despite inducing antibody responses. The ability to elicit a contraceptive response and the level of contraception induced by mouse ZP3 peptides varies depending on the genotype and strain of the mouse (East et al. 1984; Fitchen 1995; Tung et al. 1996; Hardy et al. 2002a; Hardy et al. 2004).

Nevertheless, as observed by (Hardy et al. 2002), immunofluorescence studies showed that serum anti-mZP3 antibodies could specifically react to the native ZP protein in the ovaries of wild mouse. The mZP3 antisera showed no binding to ZP in BALB/c mice, although sequence analysis revealed that mZP3 sequence is conserved between the two strains. It has been reported that under identical conditions, antibodies against mZP3 successfully reduced fertility in wild mice but had no effect on the fertility of BALB/c mice (Hardy et al. 2002). Hence, the immunological cross-reactivity between serum antibodies and ZP could indicate the ability of anti-mZP3 antibodies to bind to ZP in vivo in wild mice, which might lead to reduced fertility. Therefore, plant-produced mZP3 antigens can potentially be developed as contraceptive vaccines to manage wild mouse populations. Further research is needed to evaluate the contraceptive effect of plant-made mZP3 in wild mice.

In conclusion, the present study demonstrates that mZP3 can be effectively produced in N. benthamiana plants using a transient expression system. Compared to other production systems, plants seem to be more promising for producing highly immunogenic mZP3 antigens. Among the antigens studied, mZP3-3 is the best choice because it was efficiently expressed in the plant and induced high levels of antibodies that can react to the native zona pellucida of wild mice as the target species. Therefore, plant-produced mZP3-3 has the potential to be developed as an immunocontraceptive vaccine to control the populations of wild mice. Further research will be conducted to determine the contraceptive efficiency of plant-made mZP3-3 antigen in wild mice.

Acknowledgments

The authors would like to acknowledge Dr. Udo Meyer and Susanne Montag, Bioserv GmbH Rostock, for animal experiments and the production of anti-mZP3 antibodies. We are grateful to Dr. Susanne Radloff and Ms. Simone Krüger, Department of Life, Light & Matter, University of Rostock, for providing the fluorescence microscope and for their assistance. We are also grateful to Kerstin Thoss for technical assistance with the ELISAs.

Funding

The plant work was funded by the scholarship of the ‘Landesgraduiertenförderung’ of the University of Rostock.

Author information

Authors and Affiliations

Department of Agrobiotechnology and Risk Assessment for Bio and Gene Technology, Faculty of Agricultural and Environmental Sciences, University of Rostock, Rostock, Germany

Khadijeh Ghasemian, Inge Broer and Jana Huckauf

Department of Reproduction Biology, Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany

Jennifer Schön

BIOSERV, Analytik und Medizinprodukte GmbH, Rostock, Germany

Nadine Kolp and Richard Killisch

Author Contributions

KG designed and performed the experiments, analyzed the data and wrote the manuscript. IB and IH supervised the work, gave scientific advice and revised the manuscript. JS supervised the histological and immunofluorescence studies. NK and RK performed the animal experiment. All authors approved the manuscript.

Corresponding author

Correspondence to Jana Huckauf.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest related to the contents of this article.

Data Availability

The datasets generated during this study are available from the corresponding author on request.

Arukha AP, Minhas V, Shrestha A, Gupta SK (2016) Contraceptive efficacy of recombinant fusion protein comprising zona pellucida glycoprotein-3 fragment and gonadotropin releasing hormone. J Reprod Immunol 114:18–26. https://doi.org/10.1016/j.jri.2016.01.004
Avella MA, Xiong B, Dean J (2013) The molecular basis of gamete recognition in mice and humans. Mol Hum Reprod 19:279–289. https://doi.org/10.1093/molehr/gat004
Barber MR, Fayrer-Hosken RA (2000) Possible mechanisms of mammalian immunocontraception. J Reprod Immunol 46:103–124. https://doi.org/10.1016/s0165-0378(99)00063-7
Bechert U, Bartell J, Kutzler M, Menino A, Bildfell R, Anderson M, Fraker M (2013) Effects of two porcine zona pellucida immunocontraceptive vaccines on ovarian activity in horses. Jour Wild Mgmt 77:1386–1400. https://doi.org/10.1002/jwmg.600
Benchabane M, Goulet C, Rivard D, Faye L, Gomord V, Michaud D (2008a) Preventing unintended proteolysis in plant protein biofactories. Plant Biotechnol J 6:633–648. https://doi.org/10.1111/j.1467-7652.2008.00344.x
Bleil JD, Wassarman PM (1980) Structure and function of the zonapellucida: identification and characterization of the proteins of the mouse oocyte’s zona pellucida. Dev Biol 76:185–202. https://doi.org/10.1016/0012-1606(80)90371-1
Bosch D, Schots A (2010) Plant glycans: friend or foe in vaccine development? Expert Rev Vaccines 9:835–842. https://doi.org/10.1586/erv.10.83
Brown PR (2007) Reducing the impact of feral house mice in agricultural ecosystems. In: Lunney D, Eby P, Hutchings P, Burgin S (eds) Pest or Guest. Royal Zoological Society of New South Wales, P.O. Box 20, Mosman NSW 2088, Australia, pp 8–15. https://doi.org/10.7882/FS.2007.004
Brown PR, Henry S (2022) Impacts of House Mice on Sustainable Fodder Storage in Australia. Agronomy 12:254. https://doi.org/10.3390/agronomy12020254
Chambers LK, Singleton GR, Hood GM (1997) Immunocontraception as a potential control method of wild rodent populations. Belg J Zool 127:145–156
Chan H-T, Daniell H (2015) Plant-made oral vaccines against human infectious diseases—Are we there yet? Plant Biotechnol J 13:1056–1070. https://doi.org/10.1111/pbi.12471
Chen J, Litscher ES, Wassarman PM (1998) Inactivation of the mouse sperm receptor, mZP3, by site-directed mutagenesis of individual serine residues located at the combining site for sperm. Proc Natl Acad Sci U S A 95:6193–6197. https://doi.org/10.1073/pnas.95.11.6193
Chen Q, Lai H, Hurtado J, Stahnke J, Leuzinger K, Dent M (2013) Agroinfiltration as an Effective and Scalable Strategy of Gene Delivery for Production of Pharmaceutical Proteins. Adv Tech Biol Med 1. https://doi.org/10.4172/atbm.1000103
Choudhury S, Kakkar V, Suman P, Chakrabarti K, Vrati S, Gupta SK (2009) Immunogenicity of zona pellucida glycoprotein-3 and spermatozoa YLP12 peptides presented on Johnson grass mosaic virus-like particles. Vaccine 27:2948–2953. https://doi.org/10.1016/j.vaccine.2009.03.002
Daniell H, Singh ND, Mason H, Streatfield SJ (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14:669–679. https://doi.org/10.1016/j.tplants.2009.09.009
Daniell H, Streatfield SJ, Rybicki EP (2015) Advances in molecular farming: key technologies, scaled up production and lead targets. Plant Biotechnol J 13:1011–1012. https://doi.org/10.1111/pbi.12478
Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27:297–306. https://doi.org/10.1016/j.biotechadv.2009.01.008
Diamos AG, Mason HS (2018) Modifying the Replication of Geminiviral Vectors Reduces Cell Death and Enhances Expression of Biopharmaceutical Proteins in Nicotiana benthamiana Leaves. Front Plant Sci 9:1974. https://doi.org/10.3389/fpls.2018.01974
East IJ, Gulyas BJ, Dean J (1985) Monoclonal antibodies to the murine zona pellucida protein with sperm receptor activity: Effects on fertilization and early development. Dev Biol 109:268–273. https://doi.org/10.1016/0012-1606(85)90454-3
East IJ, Mattison DR, Dean J (1984) Monoclonal antibodies to the major protein of the murine zona pellucida: Effects on fertilization and early development. Dev Biol 104:49–56. https://doi.org/10.1016/0012-1606(84)90035-6
Engler C, Kandzia R, Marillonnet S, El-Shemy HA (2008) A One Pot, One Step, Precision Cloning Method with High Throughput Capability. PLoS ONE 3:e3647. https://doi.org/10.1371/journal.pone.0003647
Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D (2005) Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 23:1770–1778. https://doi.org/10.1016/j.vaccine.2004.11.003
Ferro VA, Mordini E (2004) Peptide vaccines in immunocontraception. Curr Opin Mol Ther 6:83–89
Firth C, Bhat M, Firth MA, Williams SH, Frye MJ, Simmonds P, Conte JM, Ng J, Garcia J, Bhuva NP, Lee B, Che X, Quan P-L, Lipkin WI (2014) Detection of zoonotic pathogens and characterization of novel viruses carried by commensal Rattus norvegicus in New York City. mBio 5:e01933–e01914. https://doi.org/10.1128/mBio.01933-14
Fitchen J (1995) Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine 13:1051–1057. https://doi.org/10.1016/0264-410X(95)00075-C
Fraser CC, Altreuter DH, Ilyinskii P, Pittet L, Lamothe RA, Keegan M, Johnston L, Kishimoto TK (2014) Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates. Vaccine 32:2896–2903. https://doi.org/10.1016/j.vaccine.2014.02.024
Garside D, Gebril A, Alsaadi M, Ferro VA (2014) Fertility control in wildlife: review of current status, including novel and future technologies. Adv Exp Med Biol 753:467–488. https://doi.org/10.1007/978-1-4939-0820-2_18
Gleba YY, Klimyuk V, Marillonnet S (2005) Magnifection–a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042–2048. https://doi.org/10.1016/j.vaccine.2005.01.006
Gupta S, Srivastava N, Choudhury S, Rath A, Sivapurapu N, Gahlay G, Batra D (2004) Update on zona pellucida glycoproteins based contraceptive vaccine. J Reprod Immunol 62:79–89. https://doi.org/10.1016/j.jri.2003.08.004
Gupta SK, Gupta N, Suman P, Choudhury S, Prakash K, Gupta T, Sriraman R, Nagendrakumar SB, Srinivasan VA (2011) Zona pellucida-based contraceptive vaccines for human and animal utility. J Reprod Immunol 88:240–246. https://doi.org/10.1016/j.jri.2011.01.011
Haigh O, Guo H, Edgtton K, Mather M, Herd KA, Tindle RW (2007) Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection. Virology 368:363–375. https://doi.org/10.1016/j.virol.2007.06.041
Hamorsky KT, Kouokam JC, Jurkiewicz JM, Nelson B, Moore LJ, Husk AS, Kajiura H, Fujiyama K, Matoba N (2015) N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential. Sci Rep 5:8003. https://doi.org/10.1038/srep08003
Hardy C (2003) Contraceptive responses of mice immunized with purified recombinant mouse zona pellucida subunit 3 (mZP3) proteins. Reproduction 126:49–59. https://doi.org/10.1530/rep.0.1260049
Hardy CM, Beaton S, Hinds LA (2008) Immunocontraception in mice using repeated, multi-antigen peptides: Immunization with purified recombinant antigens. Mol Reprod Dev 75:126–135. https://doi.org/10.1002/mrd.20745
Hardy CM, Clydesdale G, Mobbs KJ (2004) Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens. Reproduction 128:395–407. https://doi.org/10.1530/rep.1.00276
Hardy CM, ten Have JF, La Mobbs KJ Hinds (2002a) Assessment of the immunocontraceptive effect of a zona pellucida 3 peptide antigen in wild mice. Reprod Fertil Dev 14:151–155. https://doi.org/10.1071/RD01112
Hardy CM, Hinds LA, Kerr PJ, Lloyd ML, Redwood AJ, Shellam GR, Strive T (2006) Biological control of vertebrate pests using virally vectored immunocontraception. J Reprod Immunol 71:102–111. https://doi.org/10.1016/j.jri.2006.04.006
Hardy CM, Pekin J, Have J (2002b) Mouse-specific immunocontraceptive polyepitope vaccines. Reprod Suppl 60:19–30. https://doi.org/10.1530/rep.0.1230067
Hasegawa A, Hamada Y, Shigeta M, Koyama K (2002) Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA). J Reprod Immunol 53:91–98. https://doi.org/10.1016/S0165-0378(01)00084-5
Hinsch E, Oehninger S, Schill WB, Hinsch KD (1999) Species specificity of human and murine anti-ZP3 synthetic peptide antisera and use of the antibodies for localization and identification of ZP3 or ZPC domains of functional significance. Hum Reprod 14:419–428. https://doi.org/10.1093/humrep/14.2.419
Hsieh JM, Besserer GM, Madej MG, Bui H-Q, Kwon S, Abramson J (2010) Bridging the gap: a GFP-based strategy for overexpression and purification of membrane proteins with intra and extracellular C-termini. Protein Sci 19:868–880. https://doi.org/10.1002/pro.365
Hussain H, Maldonado-Agurto R, Dickson AJ (2014) The endoplasmic reticulum and unfolded protein response in the control of mammalian recombinant protein production. Biotechnol Lett 36:1581–1593. https://doi.org/10.1007/s10529-014-1537-y
Jackson RJ (1998) Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod 58:152–159. https://doi.org/10.1095/biolreprod58.1.152
Jacob J (2008) Response of small rodents to manipulations of vegetation height in agro-ecosystems. Integr Zool 3:3–10. https://doi.org/10.1111/j.1749-4877.2008.00078.x
Janczak M, Bukowski M, Górecki A, Dubin G, Dubin A, Wladyka B (2015) A systematic investigation of the stability of green fluorescent protein fusion proteins. Acta Biochim Pol 62:407–411. https://doi.org/10.18388/abp.2015_1026
Jinshu X, Jingjing L, Duan P, Zheng Z, Ding M, Jie W, Rongyue C, Zhuoyi H (2004) The immunogenicity of recombinant and dimeric gonadotrophin-releasing hormone vaccines incorporating a T-helper epitope and GnRH or repeated GnRH units. J Immunol Methods 289:111–122. https://doi.org/10.1016/j.jim.2004.04.004
Kaboodvandpour S, Leung LK-P (2010) Managing crop damage caused by house mice (Mus domesticus) in Australia. Integr Zool 5:2–14. https://doi.org/10.1111/j.1749-4877.2010.00188.x
Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V (1993) Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. J Mol recognition: JMR 6. https://doi.org/10.1002/jmr.300060206
Khan MAH, Ogita K, Ferro VA, Kumasawa K, Tsutsui T, Kimura T (2008) Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility. Vaccine 26:1365–1374. https://doi.org/10.1016/j.vaccine.2007.12.052
Kinloch RA, Sakai Y, Wassarman PM (1995) Mapping the mouse ZP3 combining site for sperm by exon swapping and site-directed mutagenesis. Proc Natl Acad Sci U S A 92:263–267. https://doi.org/10.1073/pnas.92.1.263
Komarova TV, Baschieri S, Donini M, Marusic C, Benvenuto E, Dorokhov YL (2010) Transient expression systems for plant-derived biopharmaceuticals. Expert Rev Vaccines 9:859–876. https://doi.org/10.1586/erv.10.85
Lou Y, Ang J, Thai H, McElveen F, Tung KS (1995) A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology. J Immunol 155:2715–2720. https://doi.org/10.1111/j.1600-0897.1996.tb00028.x
Ma JK-C, Drake PMW, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805. https://doi.org/10.1038/nrg117
Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS (2010) Stability of protein pharmaceuticals: an update. Pharm Res 27:544–575. https://doi.org/10.1007/s11095-009-0045-6
Margolin E, Oh YJ, Verbeek M, Naude J, Ponndorf D, Meshcheriakova YA, Peyret H, van Diepen MT, Chapman R, Meyers AE, Lomonossoff GP, Matoba N, Williamson A-L, Rybicki EP (2020) Co-expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants. Plant Biotechnol J. https://doi.org/10.1111/pbi.13369
Marillonnet S (2004) In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proceedings of the National Academy of Sciences 101:6852–6857. https://doi.org/10.1073/pnas.0400149101
Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol 23:718–723. https://doi.org/10.1038/nbt1094
Millar SE, Chamow SM, Baur AW, Oliver C, Robey F, Dean J (1989) Vaccination with a synthetic zona pellucida peptide produces long-term contraception in female mice. Science 246:935–938. https://doi.org/10.1126/science.2479101
Miller LA, Johns BE, Killian GJ (2000) Immunocontraception of white-tailed deer using native and recombinant zona pellucida vaccines. Anim Reprod Sci 63:187–195. https://doi.org/10.1016/S0378-4320(00)00177-9
Moloney MM (1995) “Molecular Farming” in Plants: Achievements and Prospects. Biotechnol Biotechnol Equip 9:3–9. https://doi.org/10.1080/13102818.1995.10818814
Mou L, Xie N (2017) Male infertility-related molecules involved in sperm-oocyte fusion. J Reprod Dev 63:1–7. https://doi.org/10.1262/jrd.2016-108
Nausch H, Broer I (2017) Cyanophycinase CphE from P. alcaligenes produced in different compartments of N. benthamiana degrades high amounts of cyanophycin in plant extracts. Appl Microbiol Biotechnol 101:2397–2413. https://doi.org/10.1007/s00253-016-8020-8
Naz RK (2005) Recent advances in contraceptive vaccine development: a mini-review. Hum Reprod 20:3271–3283. https://doi.org/10.1093/humrep/dei256
Naz RK (2008) Immunocontraceptive effect of Izumo and enhancement by combination vaccination. Mol Reprod Dev 75:336–344. https://doi.org/10.1002/mrd.20783
Naz RK, Saver AE (2016) Immunocontraception for Animals: Current Status and Future Perspective. Am J Reprod Immunol 75:426–439. https://doi.org/10.1111/aji.12431
Paterson M, Jennings Z, van Duin A, Aitken M RJ (2000) Immunocontraception with Zona pellucida Proteins. Cells Tissues Organs 166:228–232. https://doi.org/10.1159/000016735
Pinkhasov J, Alvarez ML, Rigano MM, Piensook K, Larios D, Pabst M, Grass J, Mukherjee P, Gendler SJ, Walmsley AM, Mason HS (2011) Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. Plant Biotechnol J 9:991–1001. https://doi.org/10.1111/j.1467-7652.2011.00614.x
Ponndorf D, Ehmke S, Walliser B, Thoss K, Unger C, Görs S, Daş G, Metges CC, Broer I, Nausch H (2017) Stable production of cyanophycinase in Nicotiana benthamiana and its functionality to hydrolyse cyanophycin in the murine intestine. Plant Biotechnol J 15:605–613. https://doi.org/10.1111/pbi.12658
Prasad SV, Skinner SM, Carino C, Wang N, Cartwright J (2000) Structure and function of the proteins of the mammalian Zona pellucida. Cells Tissues Organs 166:148–164. https://doi.org/10.1159/000016730
Redwood AJ, Harvey NL, Lloyd M, Lawson MA, Hardy CM, Shellam GR (2007a) Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector. Vaccine 25:698–708. https://doi.org/10.1016/j.vaccine.2006.08.021
Redwood AJ, Smith LM, Lloyd ML, Hinds LA, Hardy CM, Shellam GR (2007b) Prospects for virally vectored immunocontraception in the control of wild house mice (Mus domesticus). Wildl Res 34:530. https://doi.org/10.1071/WR07041
Rhim SH, Millar SE, Robey F, Luo AM, LOU YH, Yule T, Allen P, Dean J, Tung KS (1992) Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. J Clin Invest 89:28–35. https://doi.org/10.1172/JCI115572
Ringuette MJ, Chamberlin ME, Baur AW, Sobieski DA, Dean J (1988) Molecular analysis of cDNA coding for ZP3, a sperm binding protein of the mouse zona pellucida. Dev Biol 127:287–295. https://doi.org/10.1016/0012-1606(88)90315-6
Sabalza M, Christou P, Capell T (2014) Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks. Biotechnol Lett 36:2367–2379. https://doi.org/10.1007/s10529-014-1621-3
Sadler K, Bird PH, Brown orenaE, David C, Jackson (2000b) The antigenic and immunogenic properties of synthetic peptideimmunocontraceptive vaccine candidates based on gameteantigens. Vaccine 18:416–425. https://doi.org/10.1016/S0264-410X(99)00255-8
Samoylov A, Napier I, Morrison N, Cochran A, Schemera B, Wright J, Cattley R, Samoylova T (2019) DNA Vaccine Targeting Gonadotropin-Releasing Hormone Receptor and Its Application in Animal Contraception. Mol Biotechnol 61:73–83. https://doi.org/10.1007/s12033-018-0137-9
Sandam NP, Prakash D, Thimmareddy P (2021) Immunocontraceptive potential of a GnRH receptor-based fusion recombinant protein. J Genet Eng Biotechnol 19:63. https://doi.org/10.1186/s43141-021-00164-9
Shrestha A, Wadhwa N, Gupta SK (2014) Evaluation of recombinant fusion protein comprising dog zona pellucida glycoprotein-3 and Izumo and individual fragments as immunogens for contraception. Vaccine 32:564–571. https://doi.org/10.1016/j.vaccine.2013.11.078
Singleton GR, Brown PR, Jacob J, Aplin KP (2007) Unwanted and unintended effects of culling: A case for ecologically-based rodent management. Integr Zool 2:247–259. https://doi.org/10.1111/j.1749-4877.2007.00067.x
Stenseth NC, Leirs H, Skonhoft A, Davis SA, Pech RP, Andreassen HP, Singleton GR, Lima M, Machang’u RS, Makundi RH, Zhang Z, Brown PR, Shi D, Wan X (2003) Mice, rats, and people: the bio-economics of agricultural rodent pests. Front Ecol Environ 1:367–375. https://doi.org/10.1890/1540-9295
Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5:2–15. https://doi.org/10.1111/j.1467-7652.2006.00216.x
Streatfield SJ, Howard JA (2003) Plant-based vaccines. Int J Parasitol 33:479–493. https://doi.org/10.1016/S0020-7519(03)00052-3
Sun W (1999) A Contraceptive Peptide Vaccine Targeting Sulfated Glycoprotein ZP2 of the Mouse Zona Pellucida. Biol Reprod 60:900–907. https://doi.org/10.1095/biolreprod60.4.900
Tran TT, Hinds LA (2013) Fertility control of rodent pests: a review of the inhibitory effects of plant extracts on ovarian function. Pest Manag Sci 69:342–354. https://doi.org/10.1002/ps.3354
Tung KS, Ang J, Lou Y (1996) ZP3 peptide vaccine that induces antibody and reversible infertility without autoimmune oophoritis. Am J Reprod Immunol 35:181–183. https://doi.org/10.1111/j.1600-0897.1996.tb00028.x
Wassarman PM, Jovine L, Litscher ES (2004) Mouse zona pellucida genes and glycoproteins. Cytogenet Genome Res 105:228–234. https://doi.org/10.1159/00007819
Wondifraw BT, Tamene MY, Simegn AB (2021) Assessment of crop damage by rodent pests from experimental barley crop fields in Farta District, South Gondar, Ethiopia. PLoS ONE 16:e0255372. https://doi.org/10.1371/journal.pone.0255372

SupplementaryMaterial.docx

PDF

Reviewers agreed at journal
01 Aug, 2022
Reviewers invited by journal
21 Jul, 2022
Editor assigned by journal
16 Jul, 2022
First submitted to journal
15 Jul, 2022

You are reading this latest preprint version

Plant-produced mouse zona pellucida 3 peptide, its immunogenicity and contraceptive efficacy

Status:

Version 1

Abstract

Figures

Key Message

Introduction

Materials And Methods

Construction of plant expression vectors

Agroinfiltration procedure

Ni-NTA purification

SDS–PAGE and Western blot analysis

Enzyme-linked Immunosorbent Assay (ELISA)

Mouse Immunization

Detection of the antibody titer using ELISA

Indirect Immunofluorescence

Histological analysis

Statistical analysis

Results

Construction of expression vectors for transient expression

Purification and characterization of plant-produced mZP3 antigens

Immunogenicity of mZP3-based antigens

Fertility and ovarian effects in BALB/c mice immunized with mZP3 antigens

Reactivity of serum antibodies with the mouse ZP matrix by indirect immunofluorescence

Discussion

Declarations

References

Supplementary Files

Status:

Version 1